Local
Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Source: Hillsboro Banner

HOUSTON, Nov. 13, 2026 /PRNewswire/ -- AI-designed protein binders require wet-lab validation to confirm their target-binding activity. Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, announced its 4RISE™ high-throughput wet-lab validation services for AI-designed protein…
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Hillsboro Banner



